v3.26.1
Condensed Consolidated Statements of Net Loss and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue $ 117,683,000 $ 15,549,000 $ 198,562,000 $ 71,404,000
Cost of sales 93,808,000 11,554,000 157,226,000 65,189,000
Gross profit 23,875,000 3,995,000 41,336,000 6,215,000
Operating expenses        
Research and development 71,532,000 45,774,000 139,041,000 93,786,000
Selling, general and administrative 47,540,000 12,571,000 93,160,000 25,323,000
Total operating expenses 119,072,000 58,345,000 232,201,000 119,109,000
Loss from operations (95,197,000) (54,350,000) (190,865,000) (112,894,000)
Other income (expense), net        
Change in fair value of warrant liability (625,000) (4,191,000) (4,309,000) (1,118,000)
Interest Income 4,336,000 1,761,000 10,310,000 2,789,000
Interest expense (1,794,000) (6,998,000) (5,399,000) (13,190,000)
Gain on settlement of contingent liabilities 926,000 0 1,307,000 0
Other (expense) income, net 0 0 (7,000) 542,000
Total other income (expense), net 2,843,000 (9,428,000) 1,902,000 (10,977,000)
Loss before (benefit) provision for income taxes (92,354,000) (63,778,000) (188,963,000) (123,871,000)
Benefit (provision) for income taxes (35,000) 0 32,000 0
Net loss and comprehensive loss (92,319,000) (63,778,000) (188,995,000) (123,871,000)
Net loss available to common stockholders, basic (92,319,000) (80,263,000) (188,995,000) (152,544,000)
Net loss available to common stockholders, diluted $ (92,319,000) $ (80,263,000) $ (188,995,000) $ (152,544,000)
Net loss per common share        
Basic $ (0.57) $ (5.78) $ (1.18) $ (11.17)
Diluted $ (0.57) $ (5.78) $ (1.18) $ (11.17)
Weighted-average common shares outstanding        
Basic 161,784 13,877 160,711 13,659
Diluted 161,784 13,877 160,711 13,659
Series C Preferred Stock        
Other income (expense), net        
Less: Accretion of dividends $ 0 $ (5,363,000) $ 0 $ (10,942,000)
Series D-1 Preferred Stock        
Other income (expense), net        
Less: Accretion of dividends 0 (10,856,000) 0 (17,465,000)
Series D-3 Preferred Stock        
Other income (expense), net        
Less: Accretion of dividends $ 0 $ (266,000) $ 0 $ (266,000)